#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma B-cell lymphoma recurrent Lupus nephritis Gastrointestinal stromal tumour Solitary fibrous tumour Glomerulonephritis minimal lesion Pelizaeus-Merzbacher disease Andersen-Tawil syndrome Ewing's sarcoma Precursor T-lymphoblastic lymphoma/leukaemia recurrent Chronic myeloid leukaemia (in remission) Retinopathy of prematurity Pancreatic carcinoma Shprintzen-Goldberg syndrome Red blood cell abnormality More trials…

    Learn about Rare Diseases

    Primary immunodeficiency syndrome – Diagnostics Isodicentric chromosome 15 syndrome – Treatment Alexander disease – Life with Disease Metachromatic leukodystrophy – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Advanced systemic mastocytosis – Life with Disease Synovial sarcoma metastatic – Life with Disease Medulloblastoma – Life with Disease Pemphigoid Rhabdoid tumour – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Eptinezumab Tpst-1120 Potassium Canrenoate Acetylsalicylic Acid Azacitidine Rbl027.2 Acemetacin Sphingomyelin (Egg) Losartan Potassium Eltrombopag Ublituximab Povetacicept Elexacaftor L-METHIONINE Tilmanocept Gelatin Sonidegib YL201 Tezepelumab Mirikizumab More therapies…

    Learn about Your Condition

    Migraine without aura Marfan's syndrome Still's disease Palmoplantar pustulosis Synovial sarcoma recurrent Nephrolithiasis KBG syndrome Depression Acute HIV infection Glomerulonephritis Testicular germ cell cancer Biliary adenoma Intracranial aneurysm Paedophilia Thymoma malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on Reducing Suicidal Thoughts in Emergency Patients Using Nitrous Oxide and Oxygen Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Suicidal ideation
    Investigated Drugs:
    • Nitrogen
    • Nitrous Oxide
    • Oxygen
    France

  • Study on Buprenorphine for Treating Severe Suicidal Thoughts in Patients with Major Depression

    Recruiting

    2 1 1
    Investigated Drugs:
    • Buprenorphine
    France

  • Study on Pramipexole for Patients with Resistant Obsessive-Compulsive Disorder (OCD)

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Obsessive-compulsive disorder
    Investigated Drugs:
    • Pramipexole Dihydrochloride Monohydrate
    Portugal

  • Study on the Effects of Donepezil in Patients with Anorexia Nervosa

    Recruiting

    2 1 1
    Investigated Diseases:
    • Anorexia nervosa
    Investigated Drugs:
    • Donepezil Hydrochloride
    France

  • Study on Fluoxetine and E-therapy for Men Seeking Help with Pedophilic Disorder

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Paedophilia
    Investigated Drugs:
    • Fluoxetine
    Sweden

  • Study on the Early Effects of Ketamine and Venlafaxine for Hospitalized Patients with Severe Major Depression

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • (4R)-1-[(3-(11C)Methylpyridin-4-Yl)Methyl]-4-(3,4,5-Trifluorophenyl)Pyrrolidin-2-One
    • Ketamine
    • Venlafaxine
    France
Previous Page
1 … 14 15 16 17 18 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!